Global Non-Hodgkin lymphoma treatment Market Size, Share and Forecast 2019-2025

Posted by nabeel on February 18th, 2021

The global Non-Hodgkin lymphoma treatment market is anticipated to grow at a significant CAGR during the forecast period. The Non-Hodgkin lymphoma cancer is more common with high prevalence which will drive the Non-Hodgkin lymphoma treatment industry considerably. Non-Hodgkin lymphoma shows constitutional symptoms as well as hepatosplenomegaly symptoms. Constitutional symptoms include weight loss, hyperhidrosis, generalized hyperhidrosis, chronic pain, fatigue, and malaise. Whereas hepatosplenomegaly symptoms include abdominal pain, swelling or tenderness, nausea and vomiting, fever. 

(Get 15% Discount on Buying this Report)

To Request a Sample of our Report on Global Non-Hodgkin lymphoma treatment : 

Some lymphomas will secrete Immunoglobulin M (IgM) which leads to hyperviscosity syndrome as well as autoimmune cytopenia. Hence, rise in autoimmune diseases across the globe will significantly drive the Non-Hodgkin lymphoma treatment market. The non-Hodgkin lymphomas also secrete gammaglobulinemia which leads to infectious diseases. Thus, the increasing infection will also drive the market. 

Additionally, Non-Hodgkin lymphoma is the second most common cancer in patients with AIDS. According to the World Health Organization, 37.9 million people are living with HIV in 2018 across the globe. People living with HIV are about ten times more likely to develop Non-Hodgkin lymphoma than people without HIV. Hence the increasing AIDS cases across the globe is likely to drive the Non-Hodgkin lymphoma treatment market significantly. 

Moreover, the risk of developing Non-Hodgkin lymphoma is significantly high after organ transplant as the patient’s immunity becomes weak after the transplantation. Therefore, the increase in organ transplantation activities will also fuel the Non-Hodgkin lymphoma treatment market. In addition to this, immunosuppressed as well as congenital immune deficiency patients are also at high risk of developing Non-Hodgkin lymphoma. Hence, the patient pool of these kind of diseases will significantly impact the Non-Hodgkin lymphoma treatment industry size.

Additionally, the increasing use of radiation and chemotherapy as the first line of treatment in lymphoma cancer will also impact the Non-Hodgkin lymphoma treatment market growth. Besides, the development and advancements of therapies such as CAR-T cells are also anticipated to drive the  market during the forecast period.

Global Non-Hodgkin Lymphoma Treatment Market- Segmentation

By Cell Type

  •  B-Cell
  •  T-Cell

By Therapy Type

  •  Chemotherapy
  •  Radiation
  •  Others

Global Non-Hodgkin Lymphoma Treatment Market- Segment by Region 

North America           

  •  US
  •  Canada


  •  Germany
  •  UK
  •  France
  •  Spain
  •  Italy
  •  Rest of Europe


  •  China
  •  Japan
  •  India
  •  Rest of Asia-Pacific

Rest of the World

  •  Latin America
  •  Middle East Africa

Reasons to Buying From us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Contact Person: Mr. Anurag Tiwari


Contact no: +91 780-304-0404

Company Name: Orion Market Research

Like it? Share it!


About the Author

Joined: November 26th, 2020
Articles Posted: 337

More by this author